These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2472784

  • 1. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.
    Sedmak DD, Meineke TA, Knechtges DS.
    Arch Pathol Lab Med; 1989 Jul; 113(7):786-9. PubMed ID: 2472784
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of cytokeratin-positive breast cancer metastases.
    Sedmak DD, Meineke TA, Knechtges DS, Anderson J.
    Mod Pathol; 1989 Sep; 2(5):516-20. PubMed ID: 2479008
    [Abstract] [Full Text] [Related]

  • 3. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
    Kainz C, Gitsch G, Lee A, Danihel L, Breitenecker G.
    Anticancer Res; 1993 Sep; 13(1):73-4. PubMed ID: 7682802
    [Abstract] [Full Text] [Related]

  • 4. [Detection of metastases in breast cancer. Comparative histologic and immunohistochemical studies with monoclonal anti-cytokeratin antibodies of the axillary lymph nodes].
    Stosiek P, Kasper M, Goertchen R, Karsten U.
    Pathologe; 1986 Nov; 7(6):324-6. PubMed ID: 2433684
    [No Abstract] [Full Text] [Related]

  • 5. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
    Lachman MF, Ricci A, Pedersen CA, Cartun RW, Strumpf KB.
    Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
    [Abstract] [Full Text] [Related]

  • 6. [Intraoperative evaluation of axillary lymph nodes for micrometastases using immunohistochemistry--preliminary study].
    Sawada T, Sakurada M, Hasegawa Y, Kobayashi M.
    Rinsho Byori; 2003 Jun; 51(6):522-7. PubMed ID: 12884738
    [Abstract] [Full Text] [Related]

  • 7. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
    Wu J, Yu Z, Li G.
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.
    Cancer; 2009 Apr 15; 115(8):1605-12. PubMed ID: 19197997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
    Taha M, Ordoñez NG, Kulkarni S, Owen M, Ro JS, Hortobagyi G, Reading CL, Dicke KA, Spitzer G.
    Bone Marrow Transplant; 1989 May 15; 4(3):297-303. PubMed ID: 2471564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M.
    Cancer; 2000 Mar 01; 88(5):1099-107. PubMed ID: 10699901
    [Abstract] [Full Text] [Related]

  • 14. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.
    Byrne J, Waldron R, McAvinchey D, Dervan P.
    Eur J Surg Oncol; 1987 Oct 01; 13(5):409-11. PubMed ID: 3311817
    [Abstract] [Full Text] [Related]

  • 15. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.
    Fréneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A, Birolini MJ, Clough K, Sastre-Garau X.
    Mod Pathol; 2002 Jun 01; 15(6):641-6. PubMed ID: 12065778
    [Abstract] [Full Text] [Related]

  • 16. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA, Douglas-Jones AG, Sweetland HM, Mansel RE.
    Eur J Surg Oncol; 2006 Jun 01; 32(5):484-7. PubMed ID: 16569493
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
    Kohlberger P, Gantert M, Volk-Orlowska T, Kieback DG, Gitsch G.
    Anticancer Res; 2001 Jun 01; 21(1B):697-9. PubMed ID: 11299828
    [Abstract] [Full Text] [Related]

  • 18. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
    Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, Blamey RW, Ellis IO.
    J Pathol; 1991 Nov 01; 165(3):221-7. PubMed ID: 1722247
    [Abstract] [Full Text] [Related]

  • 19. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M, Chun J, Gill M, Bassi D, Lee S, Hibshoosh H, Mansukhani M.
    Ann Surg Oncol; 2005 Mar 01; 12(3):254-9. PubMed ID: 15827818
    [Abstract] [Full Text] [Related]

  • 20. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
    Hendler FJ, House D.
    Cancer Res; 1985 Jul 01; 45(7):3364-73. PubMed ID: 4005859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.